This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Phasing Out Use Of Highly-Enriched Uranium

By Dave Brown — Exclusive to Uranium Investing News

Phasing Out Use of Highly-Enriched Uranium

Last month, Canada's use of highly-enriched uranium (HEU) to create medica l isotopes for medical diagnoses caused controversy at the nuclear security summit in Korea. The United States, Belgium, France, South Africa, and the Netherlands have all agreed to phase out the use of HEU.

A matter of concentration

The nuclear fuel cycle begins with mining uranium and milling the ore. These recovery operations produce yellowcake, which is transported to a fuel cycle facility where it is transformed into fuel for nuclear power reactors. In addition to yellowcake, uranium recovery operations generate waste products called by-product materials. Enriched uranium is important for nuclear power reactors and for military nuclear weapons.

Reactor types and applications

HEU has a  greater than 20 percent concentration of uranium and is used in fast-neutron reactors, which require about 20 percent or more fissile material for their cores. It is also used in the production of medical isotopes, and in  naval reactors, where at least 50 percent concentration is required.

The majority of HEU  production is limited to eight research reactors, most of which are in Europe, and all but one of which are at least four decades old. As much as 95 percent of the global supply of HEU has historically been produced in Canada, Belgium, France, South Africa, and the Netherlands.

Security risk

The International Atomic Energy Agency attempts to monitor enriched uranium in order to advocate civil nuclear power generation and limit nuclear weapons proliferation. The primary objectives of the non-proliferation treaty are to reduce the spread of weapons technology and enhance cooperation in civilian use to achieve nuclear disarmament.

Fissile uranium in nuclear weapons usually contains a concentration of uranium that is 85 percent or higher, and is classified as “weapon(s)-grade.” However, for an unsophisticated or inefficient weapon, a concentration of 20 percent uranium is considered “ weapon(s)-usable,” and in theory even lower enrichment may be sufficient.

Medical isotope

Medical imaging technology uses medical isotopes in the treatment and diagnosis of many conditions, from cancer to neurological diseases. The scope of this multibillion dollar business is anticipated to grow as much as four percent annually for at least a decade.

Timothy Meyer, Head of Strategic Planning & Communications with TRIUMF, Canada's national laboratory for nuclear science, explained the implications for medical science in an exclusive interview with Uranium Investing News. “From our perspective, the increasing global pressure to move away from any and all supply chains that employ HEU is driving innovation and the development of alternative technologies. For instance, the government of Canada provided $35 million to four Canadian teams in 2012 for a two-year effort to develop methods for producing technetium-99m - the highest-demand medical isotope produced by the NRU [National Research Universal] reactor in Chalk River, Ontario - without employing nuclear reactors or uranium.” Technetium-99m is used in 85 percent of all nuclear medicine procedures, estimated globally at 20 million per year.

Alternative reactors 

Low-enriched uranium (LEU) has a concentration of uranium that is below 20 percent, and is used in commercial light water reactors. Currently these tend to be the more prominent nuclear builds, and require a uranium fuel supply that is enriched from between three to five percent.

Mining implications

Meyer explained that implications for the mining industry will be limited, commenting, “the utilization of HEU material as 'targets' for irradiation in the NRU research reactor is not a large demand on the overall uranium extraction industry. The NRU reactor is unlikely to continue producing medical isotopes using HEU until about 2016, when the current operating license for those activities expires. The HEU used by Canada's NRU for medical isotope production in the NRU is sourced from the United States.”

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,677.90 +216.58 1.32%
S&P 500 1,950.82 +23.71 1.23%
NASDAQ 4,452.7920 +69.9450 1.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs